Editorial: Innovative therapeutical approaches for hematological malignancies based on molecular targeted therapies.
Zauli
Giorgio
G
D000970:Antineoplastic Agents / Q000494:pharmacology*; D016503:Drug Delivery Systems; D019337:Hematologic Neoplasms / Q000628:therapy*; D006801:Humans; D023041:Xenograft Model Antitumor Assays
D000970:Antineoplastic Agents